| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |